Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 4, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Type 2 diabetes

Tag: Type 2 diabetes

  • Biotechnopedia
  • DNA-Tales

Oversleeping : A Serious Health Concern

DNA tales November 10, 2021November 10, 2021 2

Priyanka Saha, Amity University Kolkata Introduction It is well known that sleep is essential to the normal functioning of our bodies and for our health. After a tired and stressful day, the body needs to sleep for a minimum of 7 hours to regain its strength. But as we know, too much of anything is […]

Read More
  • BiotechToday
  • World

TCF7L2 Gene and T Allele’s impact on Type 2 Diabetes

BioTech Today August 15, 2021August 14, 2021

Saptaparna Dasgupta, Bennett University Type 2 diabetes is an impairment known to hamper the body’s ability to regulate and utilize sugar (glucose) as fuel. It is a chronic disease in which there is too much sugar in the blood. Type 2 diabetes can eventually lead to cardiovascular, neurological, and immune system problems. A prominent cause […]

Read More
  • BiotechToday
  • World

First interchangeable biosimilar insulin for diabetic patients

bioxone August 2, 2021August 1, 2021 3

Komal Bavaskar, Mumbai university Diabetes affects around 422 million people globally, with the majority residing in low- and middle-income countries, and diabetes is directly responsible for 1.6 million mortality per year. Diabetes has already been diagnosed in over 30 million people in India. What is diabetes? It is a metabolic disorder that results in elevated […]

Read More
  • BiotechToday
  • World

Gestational Diabetes Mellitus and its risks to the baby

bioxone July 13, 2021July 12, 2021

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University During pregnancy, several different hormones are produced in the body like human placental lactogen, cortisol, and progesterone for the maintenance of a healthy pregnancy. Over time the amount of these hormones increases in the body and they start resisting the effects of insulin, the hormone that is […]

Read More
  • BiotechToday
  • World

Role of hepatic GABA in obesity-related hyperphagia

BioTech Today July 4, 2021July 3, 2021

Akash Singh, Banaras Hindu University Thirty million Americans have type 2 diabetes (T2D), while another 81 million have pre-diabetes. As a result, diabetes affects 46% of the adult population in the United States, making it the seventh greatest cause of mortality in the country and accounting for one out of every seven dollars spent on […]

Read More
  • BiotechToday
  • World

Insulin treatment associated with mortality in patients with COVID-19 and Type 2 diabetes

bioxone November 29, 2020November 29, 2020 2

Subhangi Das, Bankura Sammilani College SARS-COV2 infection causing COVID-19 disease can lead to severe multi – organ injuries and significant mortality in critical patients, particularly among those people with type 2 diabetes (T2D) as a comorbidity. These patients have worse outcomes as compared to the ones without diabetes mellitus. Although attenuated mortality was observed with aggressive […]

Read More
  • BiotechToday
  • World

Type 2 Diabetes can be triggered by Prolonged Use of Common Acid Reflux Drugs

bioxone September 30, 2020September 30, 2020

-Team bioXone Research by an international team of scientists suggested that regular use of proton pump inhibitors (PPIs), commonly used to treat acid reflux, are related to a heightened risk of developing type 2 diabetes. The results also indicated that with the duration of PPI use, this risk of type 2 diabetes increases; prompting the […]

Read More
  • World

New insulin treatment for Type 2 diabetes? Find out.

bioxone September 24, 2020September 24, 2020

Prama Ghosh, Amity University Kolkata Past information has shown that patients with type 2 diabetes would by and large lean toward fewer injections and more prominent adaptability than is typical of the current once-daily insulin treatment. Therefore, decreasing the number of injections might build acknowledgment of and adherence to insulin treatment among patients with type […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy